Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis
by Elana GotkineFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published i
Updated on: April 23,2024
17

Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis
by Elana GotkineFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published i
Updated on:April 23,2024
17
